• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次颈动脉源性卒中患者的痉挛发生率及演变:一项前瞻性、纵向研究。

Prevalence and evolution of spasticity in patients suffering from first-ever stroke with carotid origin: a prospective, longitudinal study.

机构信息

Faculty of Medicine, Department of Neurology, Palacky University and University Hospital, Olomouc, Czech Republic.

Faculty of Medicine, Department of Neurology, Masaryk University and St. Anne's Teaching Hospital, Brno, Czech Republic.

出版信息

Eur J Neurol. 2019 Jun;26(6):880-886. doi: 10.1111/ene.13902. Epub 2019 Feb 8.

DOI:10.1111/ene.13902
PMID:30623522
Abstract

BACKGROUND AND PURPOSE

The main aim of the study was to document the occurrence and evolution of post-stroke spasticity (PSS). The secondary goal was to identify predictors for increases and decreases in PSS rates during 12 months of subsequent follow-up.

METHODS

In a longitudinal, multicenter, prospective cohort study, assessments were done at 7 days (V1), 6 months (V2), and 12 months (V3) after stroke onset. A total of 307 consecutive patients from four comprehensive stroke centers with the first-ever stroke of carotid origin and the presence of motor deficit at day 7 were included. The demographic data, baseline characteristics, Barthel index, degree and pattern of paresis and muscle tone were evaluated and recorded. Spasticity was assessed using the modified Ashworth scale.

RESULTS

Spasticity was present in 45.0% of patients at V1, in 49.5% at V2, and in 43.2% at V3. A significant number of patients experienced changes in spasticity between visits: increased/new occurrence of spasticity in 32.5% (V1 and V2) and in 13.6% (V2 and V3) of patients; decreased occurrence/disappearance of spasticity in 18.5% (V1 and V2) and in 18.3% (V2 and V3) of patients. The number of patients with severe spasticity increased throughout the year, from 2.6% to 13.0% (V2) and 12.5% (V3).

CONCLUSIONS

Spasticity developed in almost half of the included patients. The degree of spasticity often changed over time, in both directions. The rate of severe spasticity increased during the first year, with the maximum at 6 months following stroke onset.

摘要

背景与目的

本研究的主要目的是记录卒中后痉挛(PSS)的发生和演变。次要目标是确定在随后 12 个月的随访中 PSS 发生率增加和降低的预测因素。

方法

在一项纵向、多中心、前瞻性队列研究中,分别在卒中发病后 7 天(V1)、6 个月(V2)和 12 个月(V3)进行评估。共纳入来自 4 个综合卒中中心的 307 例首次发生颈动脉源性卒中且发病第 7 天存在运动障碍的连续患者。评估并记录人口统计学数据、基线特征、巴氏指数、瘫痪程度和模式以及肌肉张力。采用改良 Ashworth 量表评估痉挛。

结果

V1 时 45.0%的患者存在痉挛,V2 时 49.5%的患者存在痉挛,V3 时 43.2%的患者存在痉挛。大量患者在就诊时经历了痉挛的变化:32.5%(V1 和 V2)和 13.6%(V2 和 V3)的患者出现新发性痉挛;18.5%(V1 和 V2)和 18.3%(V2 和 V3)的患者痉挛发作减少或消失。严重痉挛的患者数量在一年中逐渐增加,从 2.6%增加到 13.0%(V2)和 12.5%(V3)。

结论

痉挛在纳入的患者中近一半患者中发展。痉挛的严重程度经常随时间变化,而且是双向变化的。在卒中发病后第一年,严重痉挛的发生率增加,在发病后 6 个月达到最大值。

相似文献

1
Prevalence and evolution of spasticity in patients suffering from first-ever stroke with carotid origin: a prospective, longitudinal study.首次颈动脉源性卒中患者的痉挛发生率及演变:一项前瞻性、纵向研究。
Eur J Neurol. 2019 Jun;26(6):880-886. doi: 10.1111/ene.13902. Epub 2019 Feb 8.
2
Occurence and clinical predictors of spasticity after ischemic stroke.缺血性脑卒中后痉挛的发生及临床预测因素。
Stroke. 2010 Sep;41(9):2016-20. doi: 10.1161/STROKEAHA.110.581991. Epub 2010 Aug 12.
3
Occurrence and temporal evolution of upper limb spasticity in stroke patients admitted to a rehabilitation unit.上肢痉挛在康复单元收治的脑卒中患者中的发生和时间演变。
Arch Phys Med Rehabil. 2012 Jan;93(1):143-8. doi: 10.1016/j.apmr.2011.06.027.
4
Prevalence of spasticity post stroke.中风后痉挛的患病率。
Clin Rehabil. 2002 Aug;16(5):515-22. doi: 10.1191/0269215502cr512oa.
5
Early manifestation of spasticity after first stroke in the territory of the internal carotid artery: A prospective multicenter study.颈内动脉供血区首次卒中后痉挛的早期表现:一项前瞻性多中心研究。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 May 23. doi: 10.5507/bp.2018.024.
6
Prevalence of disabling spasticity 1 year after first-ever stroke.首次卒中后1年致残性痉挛的患病率。
Eur J Neurol. 2008 Jun;15(6):533-9. doi: 10.1111/j.1468-1331.2008.02114.x. Epub 2008 Mar 18.
7
The Onset and Frequency of Spasticity After First Ever Stroke.首次脑卒中后痉挛的发作和频率。
J Natl Med Assoc. 2018 Dec;110(6):547-552. doi: 10.1016/j.jnma.2018.01.008. Epub 2018 Feb 24.
8
Toward an epidemiology of poststroke spasticity.朝向卒中后痉挛的流行病学研究。
Neurology. 2013 Jan 15;80(3 Suppl 2):S13-9. doi: 10.1212/WNL.0b013e3182762448.
9
Spasticity after stroke: its occurrence and association with motor impairments and activity limitations.中风后的痉挛状态:其发生情况以及与运动障碍和活动受限的关联
Stroke. 2004 Jan;35(1):134-9. doi: 10.1161/01.STR.0000105386.05173.5E. Epub 2003 Dec 18.
10
Spasticity and its association with functioning and health-related quality of life 18 months after stroke.中风18个月后痉挛状态及其与功能和健康相关生活质量的关联。
Cerebrovasc Dis. 2006;21(4):247-53. doi: 10.1159/000091222. Epub 2006 Jan 27.

引用本文的文献

1
Skin-Friendly Large Matrix Iontronic Sensing Meta-Fabric for Spasticity Visualization and Rehabilitation Training via Piezo-Ionic Dynamics.用于通过压离子动力学实现痉挛可视化和康复训练的亲肤大矩阵离子电子传感超织物
Nanomicro Lett. 2024 Dec 19;17(1):90. doi: 10.1007/s40820-024-01566-3.
2
Long-Term Management of Post-Stroke Spasticity with Botulinum Toxin: A Retrospective Study.脑卒后痉挛的肉毒毒素长期管理:一项回顾性研究。
Toxins (Basel). 2024 Sep 3;16(9):383. doi: 10.3390/toxins16090383.
3
Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxin.
脑卒中后痉挛:肉毒毒素慢性长期治疗的随访结果及其对功能的影响。
Eur J Phys Rehabil Med. 2024 Aug;60(4):581-590. doi: 10.23736/S1973-9087.24.08429-6. Epub 2024 Jun 18.
4
Immediate Effects of TECAR Therapy on Gastrocnemius and Quadriceps Muscles with Spastic Hypertonia in Chronic Stroke Survivors: A Randomized Controlled Trial.TECAR疗法对慢性中风幸存者腓肠肌和股四头肌痉挛性肌张力亢进的即时影响:一项随机对照试验
Biomedicines. 2023 Nov 4;11(11):2973. doi: 10.3390/biomedicines11112973.
5
Corticospinal tract: a new hope for the treatment of post-stroke spasticity.皮质脊髓束:治疗中风后痉挛的新希望。
Acta Neurol Belg. 2024 Feb;124(1):25-36. doi: 10.1007/s13760-023-02377-w. Epub 2023 Sep 13.
6
Immediate Effects of Anti-Spastic Epidural Cervical Spinal Cord Stimulation on Functional Connectivity of the Central Motor System in Patients with Stroke- and Traumatic Brain Injury-Induced Spasticity: A Pilot Resting-State Functional Magnetic Resonance Imaging Study.抗痉挛硬膜外颈脊髓刺激对中风和创伤性脑损伤所致痉挛患者中枢运动系统功能连接的即时影响:一项静息态功能磁共振成像初步研究
Biomedicines. 2023 Aug 14;11(8):2266. doi: 10.3390/biomedicines11082266.
7
Analysis of medical service utilization for post-stroke sequelae in Korea between 2016 and 2018: a cross-sectional study.2016 年至 2018 年韩国脑卒中后遗症医疗服务利用情况分析:一项横断面研究。
Sci Rep. 2022 Nov 28;12(1):20501. doi: 10.1038/s41598-022-24710-8.
8
Early Use of Phenol Neurolysis Likely Reduces the Total Amount of Botulinum Toxin in Management of Post-Stroke Spasticity.早期使用苯酚神经溶解术可能会减少肉毒杆菌毒素在中风后痉挛管理中的总用量。
Front Rehabil Sci. 2021 Sep 16;2:729178. doi: 10.3389/fresc.2021.729178. eCollection 2021.
9
Aging after stroke: how to define post-stroke sarcopenia and what are its risk factors?中风后的衰老:如何定义中风后肌少症及其危险因素?
Eur J Phys Rehabil Med. 2022 Oct;58(5):683-692. doi: 10.23736/S1973-9087.22.07514-1. Epub 2022 Sep 5.
10
Comprehensive Assessment of the Time Course of Biomechanical, Electrophysiological and Neuro-Motor Effects after Botulinum Toxin Injections in Elbow Flexors of Chronic Stroke Survivors with Spastic Hemiplegia: A Cross Sectional Observation Study.慢性脑卒中痉挛性偏瘫患者肱二头肌注射肉毒毒素后生物力学、电生理和神经运动效应时间过程的综合评估:一项横断面观察研究。
Toxins (Basel). 2022 Jan 28;14(2):104. doi: 10.3390/toxins14020104.